𝔖 Bobbio Scriptorium

✦ LIBER ✦

Might Men Diagnosed with Metastatic Prostate Cancer Benefit from Definitive Treatment of the Primary Tumor? A SEER-Based Study

✍ Scribed by Andriole, G.L.

Book ID: 126905903
Publisher: Elsevier Science
Year: 2014
Weight: 136 KB
Volume: 2014
Category: Article
ISSN: 0084-4071
DOI: 10.1016/j.yuro.2014.07.022

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Re: Stephen H. Culp, Paul F. Schellhamme

Re: Stephen H. Culp, Paul F. Schellhammer, Michael B. Williams. Might Men Diagnosed with Metastatic Prostate Cancer Benefit from Definitive Treatment of the Primary Tumor? A SEER-based Study. Eur Urol 2014;65:1058–66

✍ Bayne, Christopher E. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 155 KB

Re: Stephen H. Culp, Paul F. Schellhamme

Re: Stephen H. Culp, Paul F. Schellhammer, Michael B. Williams. Might Men Diagnosed with Metastatic Prostate Cancer Benefit from Definitive Treatment of the Primary Tumor? A SEER-Based Study. Eur Urol 2014;65:1058–66

✍ Ost, Piet; Briganti, Alberto; Giannarini, Gianluca 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 159 KB

Prognostic impact of definitive local th

Prognostic impact of definitive local therapy of the primary tumor in men with metastatic prostate cancer at diagnosis: A population-based, propensity score analysis

✍ Antwi, Samuel; Everson, Todd M. 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 539 KB

662 THE SURVIVAL BENEFIT OF PRIOR DEFINI

662 THE SURVIVAL BENEFIT OF PRIOR DEFINITIVE LOCAL THERAPY IN MEN WITH ADVANCED/METASTATIC PROSTATE CANCER: RESULTS FROM A PHASE III PROSPECTIVE RANDOMIZED TRIAL

✍ Williams, Michael; Millikan, Randall; Wang, Xuemei; Pettaway, Curtis 📂 Article 📅 2010 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 43 KB

Evidence-based oncology mitomycin C prov

Evidence-based oncology mitomycin C provides little additional benefit in the treatment of carcinoma of unknown primary site: Abstracted from: Assersohn L, Norman AR, Cunningham D et al. A randomised study of protracted venous infusion of 5-fluorouracil (5-FU) with or without bolus mitomycin C (MMC) in patients with carcinoma of unknown primary. European Journal of Cancer 2003; 39: 1121–1128

✍ Jonathan E Dowell 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 65 KB